Latham, Davis Polk, Whalen Guide GoodRx's $1.1B IPO

Law360 (September 23, 2020, 6:01 PM EDT) -- Shares of GoodRx, whose platform helps users find coupons and compare prices for prescription drugs, took off Wednesday as the company raised $1.1 billion to support business growth in an initial public offering guided by Latham, Davis Polk and Whalen.

Latham & Watkins LLP-led GoodRx Holdings Inc.'s 34.6 million shares — including 23.4 million offered by the company and nearly 11.2 million being sold by shareholders — began trading on Nasdaq under the ticker symbol "GDRX." The company offered the shares at $33 each, according to a press release, well above the original range of $24 to $28 that would have...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!